HucMDEs not only improved insulin resistance and increased insulin sensitivity in T2DM rats but also relieved liver dysfunction and improve lipid profiles, as evidenced by significantly decreased serum levels of ALT, AST, TC, and TG. This evidence concerns the gene INS and type 2 diabetes mellitus.